Skip to main content
Advertisement
Advertisement

TELO

TELO logo

Telomir Pharmaceuticals, Inc. Common Stock

1.22
USD
Sponsored
-0.03
-2.40%
Sep 23, 15:59 UTC -4
Closed
exchange

After-Market

1.21

-0.01
-0.82%

TELO Earnings Reports

Positive Surprise Ratio

TELO beat 2 of 5 last estimates.

40%

Next Report

Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$510.00K
/
-$0.08
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
+166.67%

Telomir Pharmaceuticals, Inc. Common Stock earnings per share and revenue

On Aug 12, 2026, TELO reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.07 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.08 USD, with revenue projected to reach 510.00 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Telomir Pharmaceuticals, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Nov 09, 2026.
Based on 3 analysts, Telomir Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$0.08 and revenue of $510.00K for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement